HBV3 O‐29: A randomized comparative open label trial of tenofovir monotherapy versus tenofovir plus telbuvidine dual therapy in spontaneous reactivation of hepatitis B (NCT01732224)

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|22|S2|17-18

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.S2, 2015-06, pp. : 17-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

P062: A randomized comparative open label trial of tenofovir monotherapy versus tenofovir plus telbuvidine dual therapy in spontaneous reactivation of hepatitis B (NCT01732224)

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 51-51

John Wiley & Sons Inc

Access to resources Recommend Favorite

First report of successful clearance of hepatitis B and D coinfection with tenofovir monotherapy

By  

HEPATOLOGY, Vol. 62, Iss. 1, 2015-07 ,pp. : 317-318

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 1398-2273, Iss. 5, 2015-10 ,pp. : 695-701

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 5, 2015-10 ,pp. : 695-701

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tenofovir in the treatment of chronic hepatitis B

By Yu Derek   Heathcote Jenny  

Therapy, Vol. 8, Iss. 5, 2011-09 ,pp. : 527-544

Future Medicine

Access to resources Recommend Favorite